Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:alsoKnownAs |
gptkb:Samsara_Capital
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
early-stage investments
growth-stage investments |
| gptkbp:foundedIn |
2017
|
| https://www.w3.org/2000/01/rdf-schema#label |
Samsara BioCapital
|
| gptkbp:industry |
gptkb:biotechnology
life sciences |
| gptkbp:investedIn |
life sciences companies
biotech companies |
| gptkbp:location |
gptkb:Palo_Alto,_California
|
| gptkbp:managingPartner |
gptkb:Srinivas_Akkaraju
|
| gptkbp:notableInvestment |
gptkb:Sana_Biotechnology
gptkb:Arcutis_Biotherapeutics gptkb:Cortexyme gptkb:Denali_Therapeutics gptkb:Imara_Inc. gptkb:Nkarta_Therapeutics gptkb:Orchard_Therapeutics gptkb:Tango_Therapeutics gptkb:Alector |
| gptkbp:website |
https://www.samsaracap.com/
|
| gptkbp:bfsParent |
gptkb:Scribe_Therapeutics
|
| gptkbp:bfsLayer |
5
|